Back
Armata Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
ARMP
Armata Pharmaceuticals
Last Price:
$2.46
Seasonality Move:
-0.08%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARMP is experiencing slight selling pressure.
Armata Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.25 | Buy |
| 20-day SMA: | 2.06 | Buy |
| 50-day SMA: | 1.9 | Buy |
| 200-day SMA: | 1.98 | Buy |
| 8-day EMA: | 2.26 | Buy |
| 20-day EMA: | 2.12 | Buy |
| 50-day EMA: | 1.95 | Buy |
| 200-day EMA: | 2.01 | Buy |
Armata Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 62.8 | Buy |
| Chaikin Money Flow: | -5145 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.87 - 2.21) | Buy |
| Bollinger Bands (100): | (1.39 - 2.13) | Buy |
Armata Pharmaceuticals Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Armata Pharmaceuticals Stock
Is Armata Pharmaceuticals Stock a Buy?
-
Armata Pharmaceuticals share price is 2.36 while ARMP 8-day simple moving average is 2.25, which is a Buy signal.
-
The stock price of ARMP is 2.36 while Armata Pharmaceuticals 20-day SMA is 2.06, which makes it a Buy.
-
Armata Pharmaceuticals 50-day simple moving average is 1.90 while ARMP share price is 2.36, making it a Buy technically.
-
ARMP stock price is 2.36 and Armata Pharmaceuticals 200-day simple moving average is 1.98, creating a Buy signal.
ARMP Technical Analysis vs Fundamental Analysis
Buy
51
Armata Pharmaceuticals (ARMP)
is a Buy
Is Armata Pharmaceuticals a Buy or a Sell?
-
Armata Pharmaceuticals stock is rated a BuyThe current Armata Pharmaceuticals [ARMP] share price is $2.36. The Score for ARMP is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Armata Pharmaceuticals Stock Info
Market Cap:
85.4M
Price in USD:
2.36
Share Volume:
18K
Armata Pharmaceuticals 52-Week Range
52-Week High:
3.42
52-Week Low:
0.90
Buy
51
Armata Pharmaceuticals (ARMP)
is a Buy
Armata Pharmaceuticals Share Price Forecast
-
What is the Armata Pharmaceuticals stock price today?The Armata Pharmaceuticals stock price is 2.36 USD today.
-
Will ARMP stock go up or go down?Armata Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Armata Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Armata Pharmaceuticals is not overvalued.
Is Armata Pharmaceuticals Stock a Buy?
-
Armata Pharmaceuticals share price is 2.36 while ARMP 8-day exponential moving average is 2.26, which is a Buy signal.
-
The stock price of ARMP is 2.36 while Armata Pharmaceuticals 20-day EMA is 2.12, which makes it a Buy.
-
Armata Pharmaceuticals 50-day exponential moving average is 1.95 while ARMP share price is 2.36, making it a Buy technically.
-
ARMP stock price is 2.36 and Armata Pharmaceuticals 200-day simple moving average is 2.01, creating a Buy signal.
Fundamental Analysis of Armata Pharmaceuticals
Is Armata Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.99 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Armata Pharmaceuticals
Should I short Armata Pharmaceuticals stock?
-
ARMP Moving Average Covergence Divergence (MACD) indicator is 0.13, suggesting Armata Pharmaceuticals is a Buy
-
Armata Pharmaceuticals Relative Strength Index (RSI) is 62.8, which suggest Armata Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Armata Pharmaceuticals is (1.87 - 2.21), which suggest Armata Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Armata Pharmaceuticals is (1.39 - 2.13), which suggest Armata Pharmaceuticals is a Buy
* Armata Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.